2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Cytotherapy
Cytotherapy represents a promising avenue in cancer research, leveraging the body's own cells to combat the disease. This innovative approach involves harnessing the power of immune cells, such as T cells, to target and destroy cancerous cells. One notable technique is CAR-T cell therapy, where T cells are genetically modified to express chimeric antigen receptors (CARs) that recognize specific proteins on cancer cells. Upon infusion back into the patient, these engineered T cells can effectively seek out and eliminate tumors.
Moreover, cytotherapy extends beyond CAR-T cells, encompassing various strategies like dendritic cell vaccines and natural killer (NK) cell therapy. These therapies hold immense potential for personalized cancer treatment, offering tailored solutions based on individual immune profiles. As research progresses, cytotherapy continues to evolve, bringing hope for more effective and targeted cancer therapies with potentially fewer side effects.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China